Results 191 to 200 of about 79,811 (267)

Multi-functionalized biologically active isatin-tagged dihydropyrimidine derivatives: green synthesis by the use of recyclable Fe-dopped Ce-oxide nanoparticles, computational studies and <i>ex vivo</i> cytotoxic activity against breast cancer cells. [PDF]

RSC Adv
Saini KK, Upadhyay RK, Rani D, Kaur S, Kant R, Dey SK, Kumar R.   +6 more
europepmc   +1 more source

Aotaphenazine, a rare hydrophenazine, targets topoisomerase II with anticancer efficacy: In silico to in vitro evidence. [PDF]

PLoS One
Metwaly AM, Eissa IH, Afifi WM, Elkaeed EB, Alsfouk AA, Ibrahim IM, Abdelfattah MS.   +6 more
europepmc   +1 more source

Figure S3 from A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors [PDF]

Tona M. Gilmer, Chun-Hsiang Lai, Kexiao Guo, Katherine Deland, Kathleen A. Ashcraft, Amy E. Stewart, Yaode Wang, Jianmin Fu, Kris C. Wood, David G. Kirsch, Michael B. Kastan   +10 more
openalex   +1 more source

Design, synthesis and SAR of novel naphthalene-sulfonamide hybrids: anticancer assessment, gene expression analysis of IL6/JAK2/STAT3 signaling in MCF7 cells and antimicrobial evaluation. [PDF]

RSC Adv
Elsayed GH, Abdelazeem NM, Saleh AM, Abd El-Moez S, El-Hussieny M, Al-Ashmawy AAK.   +5 more
europepmc   +1 more source

Molecular characterization of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae susceptible to delafloxacin. [PDF]

J Antimicrob Chemother
Cercenado E, Marín M, Iglesias M, Jiménez L, Pérez-Abeledo M, Sanz JC.   +5 more
europepmc   +1 more source

A Novel Mechanism of Cell Killing by Anti-topoisomerase II Bisdioxopiperazines

, 2000
Lars H. Jensen, Karin C. Nitiss, Angela Rose, Jiaowang Dong, Junfang Zhou, Hu Tao, Neil Osheroff, Peter Buhl Jensen, Maxwell Sehested, John L. Nitiss   +9 more
openalex   +1 more source

Antibody drugs conjugates in small-cell lung cancer: present-day status and promises. [PDF]

Oncologist
Syal A, Meyer ML, Angelino K, Osei N, Gomez JE, Hirsch FR, Sen T.   +6 more
europepmc   +1 more source

Topoisomerase II and IV QuinoloneResistance-Determining Regions in Stenotrophomonas maltophilia Clinical Isolates with Different Levels of QuinoloneSusceptibility

, 2002
Sylvia Valdezate, Ana Vindel, A. Echeíta, Fernando Baquero, Rafael Cantó   +4 more
openalex   +1 more source

Immunological mechanisms and antibody-drug conjugates targeting B7-H3 and B7-H4 in ovarian cancer. [PDF]

Front Immunol
Brown EF, Colombo I, Madariaga A, Kasherman L.   +3 more
europepmc   +1 more source

Anthraquinones from Neonauclea calycina and Their Inhibitory Activity against DNA Topoisomerase II.

, 1998
Hideki Tosa, Munekazu Iinuma, Fujio Asai, Toshiyuki Tanaka, Hirōshi Nozaki, Shougo IKEDA, Ken TSUTSUI, Kimiko Tsutsui, Masashi Yamada, Shiho FUJIMORI   +9 more
openalex   +2 more sources